What NEUCA S.A.'s (WSE:NEU) P/E Is Not Telling You
Dec 12
Have your own idea? Try our Stock Screener
Polish (WIG) Healthcare Sector Analysis
UpdatedDec 22, 2024
DataAggregated Company Financials
Companies47
- 7D-2.6%
- 3M-6.3%
- 1Y-2.0%
- YTD-0.9%
Over the last 7 days, the Healthcare industry has dropped 2.6%, driven by a pullback from Selvita of 11%. In contrast, EMC Instytut Medyczny has gained 6.8%. Over the last year, the industry has been flat overall. Looking forward, earnings are forecast to grow by 9.2% annually.
Sector Valuation and Performance
Has the Polish Healthcare Sector valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Sun, 22 Dec 2024 | zł14.7b | zł16.7b | zł123.0m | 24.3x | 119.2x | 0.9x |
| Tue, 19 Nov 2024 | zł14.7b | zł16.4b | zł53.4m | 21.1x | 275.9x | 0.9x |
| Thu, 17 Oct 2024 | zł15.8b | zł16.4b | zł82.2m | 23.6x | 192.3x | 1x |
| Sat, 14 Sep 2024 | zł15.4b | zł16.4b | zł161.0m | 28.6x | 95.9x | 0.9x |
| Mon, 12 Aug 2024 | zł14.8b | zł16.2b | zł131.5m | 28.4x | 112.6x | 0.9x |
| Wed, 10 Jul 2024 | zł15.4b | zł16.2b | zł134.2m | 28.6x | 115x | 1x |
| Fri, 07 Jun 2024 | zł14.9b | zł16.2b | zł100.2m | 27x | 149x | 0.9x |
| Sun, 05 May 2024 | zł14.7b | zł16.0b | zł85.9m | 38.7x | 171.3x | 0.9x |
| Tue, 02 Apr 2024 | zł15.0b | zł14.4b | -zł222,216,549.00 | 39.7x | -67.4x | 1x |
| Thu, 29 Feb 2024 | zł14.8b | zł16.0b | -zł199,514,549.00 | 40.2x | -74.4x | 0.9x |
| Sat, 27 Jan 2024 | zł14.9b | zł15.9b | -zł247,198,884.00 | 34.5x | -60.4x | 0.9x |
| Mon, 25 Dec 2023 | zł15.0b | zł15.9b | -zł245,263,080.00 | 30.9x | -61.2x | 0.9x |
| Wed, 22 Nov 2023 | zł13.6b | zł15.9b | zł145.4m | 29.6x | 93.7x | 0.9x |
| Fri, 20 Oct 2023 | zł13.9b | zł15.7b | zł114.5m | 31.1x | 121x | 0.9x |
| Sun, 17 Sep 2023 | zł14.2b | zł15.7b | zł78.8m | 19.2x | 180.8x | 0.9x |
| Tue, 15 Aug 2023 | zł14.5b | zł15.4b | zł111.6m | 24.8x | 130.3x | 0.9x |
| Thu, 13 Jul 2023 | zł14.5b | zł15.4b | zł101.1m | 26.1x | 143.8x | 0.9x |
| Sat, 10 Jun 2023 | zł14.2b | zł15.5b | zł186.6m | 24.7x | 76x | 0.9x |
| Mon, 08 May 2023 | zł13.6b | zł15.3b | zł205.0m | 27.1x | 66.3x | 0.9x |
| Wed, 05 Apr 2023 | zł13.0b | zł15.4b | zł248.1m | 25.4x | 52.3x | 0.8x |
| Fri, 03 Mar 2023 | zł13.7b | zł15.1b | zł259.2m | 28.4x | 52.8x | 0.9x |
| Sun, 29 Jan 2023 | zł13.5b | zł15.0b | zł237.9m | 26.9x | 56.6x | 0.9x |
| Tue, 27 Dec 2022 | zł12.2b | zł15.0b | zł230.0m | 25.1x | 53.1x | 0.8x |
| Thu, 24 Nov 2022 | zł12.4b | zł15.1b | -zł131,717,085.00 | 21.5x | -94x | 0.8x |
| Sat, 22 Oct 2022 | zł11.4b | zł14.8b | -zł130,100,544.00 | 22.8x | -87.6x | 0.8x |
| Mon, 19 Sep 2022 | zł12.2b | zł15.0b | zł248.3m | 20x | 49x | 0.8x |
| Wed, 17 Aug 2022 | zł13.2b | zł14.7b | zł275.5m | 22.5x | 48x | 0.9x |
| Fri, 15 Jul 2022 | zł12.1b | zł14.8b | zł265.8m | 19x | 45.4x | 0.8x |
| Sun, 12 Jun 2022 | zł12.2b | zł14.8b | zł267.5m | 17.9x | 45.6x | 0.8x |
| Tue, 10 May 2022 | zł12.7b | zł14.9b | zł850.7m | 24.5x | 14.9x | 0.9x |
| Thu, 07 Apr 2022 | zł14.8b | zł14.9b | zł908.2m | 23.4x | 16.3x | 1x |
| Sat, 05 Mar 2022 | zł13.9b | zł14.8b | zł906.6m | 19.9x | 15.3x | 0.9x |
| Mon, 31 Jan 2022 | zł15.6b | zł14.9b | zł936.2m | 22.9x | 16.7x | 1.1x |
| Wed, 29 Dec 2021 | zł16.8b | zł14.8b | zł930.4m | 25.4x | 18.1x | 1.1x |
Price to Earnings Ratio
18.1x
Current Industry PE
- Investors are optimistic on the Polish Healthcare industry, and appear confident in long term growth rates.
- The industry is trading at a PE ratio of 119x which is higher than its 3-year average PE of 53.2x.
- The industry is trading close to its 3-year average PS ratio of 0.92x.
Past Earnings Growth
- The earnings for companies in the Healthcare industry have declined 49% per year over the last three years.
- Meanwhile revenues for these companies have grown 3.9% per year.
- This means that although more sales are being generated, either the cost of doing business or the level of investment back into businesses has increased, which has decreased profits.
Industry Trends
Which industries have driven the changes within the Polish Healthcare sector?
| PL Market | -2.62% | |
| Healthcare | -2.63% | |
| Pharma | 0.56% | |
| Healthtech | -0.90% | |
| Healthcare Services | -1.43% | |
| Biotech | -3.39% | |
| Medical Equipment | -4.07% | |
| Life Sciences | -8.19% | |
Industry PE
- Investors are most optimistic about the Healthcare Services industry even though it's trading below its 3-year average PE ratio of 27.6x.
- Analysts are expecting annual earnings growth of 18.0%, which is lower than the prior year's growth of 26.3% per year.
Forecasted Growth
- Analysts are most optimistic on the Biotech industry, expecting annual earnings growth of 28% over the next 5 years.
- This is roughly in line with its past earnings growth rate.
- In contrast, the Pharma industry is expected to see its earnings decline by 30% per year over the next few years.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| EMC EMC Instytut Medyczny | zł11.00 | 6.8% +zł29.4m | 25.0% | PE38.7x | |
| BCX Bioceltix | zł83.50 | 7.2% +zł27.6m | -4.9% | PB9.9x | |
| SVE Synthaverse | zł4.25 | 6.1% +zł17.2m | -3.3% | PE67.1x | |
| CLN Celon Pharma | zł25.00 | 1.0% +zł13.5m | 56.8% | PE72.7x | |
| NNG NanoGroup | zł2.74 | 13.2% +zł9.0m | 195.3% | PS38170.1x |
